Activation, coactivation, and costimulation of resting human natural killer cells - Wikidata - awgldk - TriplyDB

Activation, coactivation, and costimulation of resting human natural killer cells

Activation, coactivation, and costimulation of resting human natural killer cells

http://www.wikidata.org/entity/Q36652166

about

The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies Newtonian cell interactions shape natural killer cell education Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata NMR solution conformations and interactions of integrin alphaLbeta2 cytoplasmic tails Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector Functions Proteome analysis of distinct developmental stages of human natural killer (NK) cells Kinome analysis of receptor-induced phosphorylation in human natural killer cells Innate or adaptive immunity? The example of natural killer cells Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages.Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse Model hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase Regulation of human NK-cell cytokine and chemokine production by target cell recognition.Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients.T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling NK cell-based immunotherapy for malignant diseases.Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.Innate immune natural killer cells and their role in HIV and SIV infection.TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.Natural Killer Cells in Viral Hepatitis.Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins.The Memories of NK Cells: Innate-Adaptive Immune Intrinsic Crosstalk.ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantation Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis.Essential role of NK cells in IgG therapy for experimental autoimmune encephalomyelitis Selective role of mevalonate pathway in regulating perforin but not FasL and TNFalpha release in human Natural Killer cells

P2860

Q21144323-B4ECA013-86BE-48F5-A3B5-25CAFCE577E5 Q24616577-171E645D-8F73-4A1F-874A-EF21517D6B61 Q26776538-E78A1840-AD67-4753-95E2-E4E76AA9D4B1 Q26797240-B8FDF092-486C-4275-967A-017D8C9766B9 Q27011716-FA28BA27-B552-4CA9-8EA5-0F2F8136F3F6 Q27653113-F470A7AB-BC1F-4F6D-A033-5ADB2D75CAA9 Q28550076-FA8A489D-F1E0-4658-B379-6F14F598F861 Q28574498-F0D11435-31F7-4BCC-B655-98317CC6E9A4 Q28703128-34B8B425-E905-461A-A66C-EB05475A566E Q28704450-00A622F4-1436-4D14-8E76-E9466BCBD55D Q28740357-D3DA35A7-7389-4435-8510-CABA09AD180B Q29615106-BEBE6D2F-2F53-4A75-A64B-7F984ADF2B40 Q30388401-9D262125-C96F-4025-B144-8F836453A6D4 Q30440293-FB99410A-AAF3-497C-86BD-91B3FCE12EBE Q30544833-F7352C38-8BE5-41C7-9127-1DFD3450513F Q30668576-BDAB2168-1901-4FA8-99C7-BABE38508F93 Q33292180-CF239B61-CD6F-49CB-8CBE-3E7A039A77EB Q33396615-FDEFE0C1-90BC-42EA-947C-500A3359F01E Q33629253-4D1B6627-14FC-4D5E-96A2-61ECB81B8A88 Q33730462-0ACFBC7A-89ED-4346-9D96-67BEF800737D Q33745662-76A86303-329E-470B-B282-3273D70AA420 Q33747309-2A5F353F-442E-48D6-A5E6-E50903B86161 Q33758290-92F17E9D-5485-43CB-952C-55CB7EFCC47F Q33792958-901247D5-5D2E-442E-B9D6-5FA52EF59D8F Q33827433-E58A30B2-00EF-4BB5-B450-50A26ACA23D1 Q33828594-C98B78F7-9E51-416B-858B-8DE62799C527 Q34070433-AAA50FCD-BBEB-4614-AA0E-E78B5ED00771 Q34205905-957D2F23-9EDA-4842-B0BD-F988C93DAA0D Q34287535-26AD7DF7-6A2D-4BBE-AB70-688C3C41EEA0 Q34402566-17D96360-20C2-452A-871B-EBB58922ED41 Q34423336-22E23EE4-350E-4A5E-8943-02608A300944 Q34501427-D436670A-58BE-4CD7-963B-586D2C4C01A6 Q34505690-CFE68729-AC5F-4871-A0C6-B33963B30ED7 Q34548289-6B992D71-1201-42B9-AB12-08637568C7D2 Q34549025-AC93D8D8-C551-4D74-A832-7132646DF3C5 Q34602870-58BD4EB8-2BB2-47B4-BF72-5061BB1EE36F Q34618829-A786A7E3-8E8F-423E-8339-CABF63D68993 Q34649745-B4271FEC-C5E9-4520-9601-B811BD42AC80 Q34664020-609B24FD-D0BB-4ADF-8318-B824521CCE78 Q34717893-7CFA7F9F-8035-4410-82CA-1FA1B2937D9E

P2860

Activation, coactivation, and costimulation of resting human natural killer cells

http://www.wikidata.org/entity/Q36652166

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Activation, coactivation, and costimulation of resting human natural killer cells

@ast

Activation, coactivation, and costimulation of resting human natural killer cells

@en

type

label

Activation, coactivation, and costimulation of resting human natural killer cells

@ast

Activation, coactivation, and costimulation of resting human natural killer cells

@en

prefLabel

Activation, coactivation, and costimulation of resting human natural killer cells

@ast

Activation, coactivation, and costimulation of resting human natural killer cells

@en

P1433

Q36652166-071B6AFE-D154-4A64-A903-C7C198039A0F

P1476

Q36652166-33D010C9-3B49-4C73-BBA9-83D6C545D7B1

P2093

Q36652166-009CDB20-27AB-4750-A01A-1754593B5BF8

Q36652166-9F4900B1-9D8F-491B-8762-9152824E5D86

P2860

Q36652166-043F9507-D13D-4C30-815A-DDDA054537C9

Q36652166-04D850A5-C1F6-420A-92DD-36BCC63A93D1

Q36652166-064CDCCA-C32A-40A9-AE0A-2C1766B4D3A6

Q36652166-06D83BC7-8CD1-4C82-A764-B0C247BC0FDC

Q36652166-07D2DEC7-C3C8-42B2-81C4-72483A497C8D

Q36652166-098A0B97-B4E9-4423-8322-0578C07DD673

Q36652166-0B523F90-EC26-449F-B688-74947548007F

Q36652166-0BC0EDA2-1003-4083-91C0-15AD83E0840D

Q36652166-0CEA8E24-DC09-41F8-B991-D577B1F9CDD3

Q36652166-0D005255-CD7F-4249-8E07-4FC15694CD9E

P304

Q36652166-60B10E87-142D-4F3B-A929-B924BFD18436

P31

Q36652166-51DEB669-55F7-433E-8AA6-06A19484EFE3

P356

Q36652166-385B0686-9B6A-42BF-B38C-1E355D4A6A88

P478

Q36652166-62D56A67-DAD0-4BEF-95A9-1C1629C81D08

P50

Q36652166-3F176A88-A963-45AA-929B-42329D9E6F79

Q36652166-6B181919-E39E-47F7-8A32-E2AF548F6AEA

P577

Q36652166-F874C016-31A7-4431-8FF0-512A7503F4BB

P698

Q36652166-C8A8B926-5366-4300-8498-5AD647E61456

P932

Q36652166-C2A81C12-EBFA-435C-9913-0A892E4D7C3C

P356

J.1600-065X.2006.00457.X

P1433

Immunological Reviews

P1476

Activation, coactivation, and costimulation of resting human natural killer cells

@en

P2093

Eric O Long

http://www.w3.org/2001/XMLSchema#string

Hans-Gustaf Ljunggren

http://www.w3.org/2001/XMLSchema#string

P2860

MAFA-L, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

An activating immunoreceptor complex formed by NKG2D and DAP10

Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells

Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes

Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1

P304

73-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-065X.2006.00457.X

http://www.w3.org/2001/XMLSchema#string

P478

214

http://www.w3.org/2001/XMLSchema#string

P50

Yenan T Bryceson

Michael E. March

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17100877

http://www.w3.org/2001/XMLSchema#string

P932

3845883

http://www.w3.org/2001/XMLSchema#string